Hadjinor, Darwisa .

HRN: 21-10-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 500MG (TAB)
10/17/2023
10/24/2023
PO
500 Mg Tab
BID
S/P REPEAT LSCS
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: